129 related articles for article (PubMed ID: 29779857)
1. Factors affecting the incidence of contrast-induced nephropathy in patients undergoing computed tomography.
Heras Benito M; Garrido Blázquez M; Gómez Sanz Y; Bernardez Mardomingo M; Ruiz Cacho J; Rodríguez Recio FJ; Fernández-Reyes Luis MJ
Radiologia (Engl Ed); 2018; 60(4):326-331. PubMed ID: 29779857
[TBL] [Abstract][Full Text] [Related]
2. Incidence of contrast-induced nephropathy after a computed tomography scan.
Barrios López A; García Martínez F; Rodríguez JI; Montero-San-Martín B; Gómez Rioja R; Diez J; Martín-Hervás C
Radiologia (Engl Ed); 2021; 63(4):307-313. PubMed ID: 34246421
[TBL] [Abstract][Full Text] [Related]
3. The administration of contrast media: is there a risk of acute kidney injury?
Ferrer Puchol MD; Montesinos García P; Forment Navarro M; Sanz Rodrigo E; Blanco Pérez E; Taberner López E
Radiologia (Engl Ed); 2019; 61(4):306-314. PubMed ID: 30910216
[TBL] [Abstract][Full Text] [Related]
4. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
[TBL] [Abstract][Full Text] [Related]
5. Use of cystatin C and serum creatinine for the diagnosis of contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography at an oncology centre.
Fortalesa Melo JI; Chojniak R; Costa Silva DH; Oliveira Junior JC; Vieira Bitencourt AG; Holanda Silva D; Guimarães MD; Silva HC; Dias DG; Rodrigues WC; Brancucci EL; Cruz BM; Schiavon BN; Argenton JL; Camporini MA; Zocchio A
PLoS One; 2015; 10(5):e0122877. PubMed ID: 25961558
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
Huber W; Eckel F; Hennig M; Rosenbrock H; Wacker A; Saur D; Sennefelder A; Hennico R; Schenk C; Meining A; Schmelz R; Fritsch R; Weiss W; Hamar P; Heemann U; Schmid RM
Radiology; 2006 Jun; 239(3):793-804. PubMed ID: 16714461
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT.
Ho YF; Hsieh KL; Kung FL; Wu FL; Hsieh LL; Chou H; Chen SJ
AJR Am J Roentgenol; 2015 Oct; 205(4):703-8. PubMed ID: 26397318
[TBL] [Abstract][Full Text] [Related]
9. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
Pahade JK; LeBedis CA; Raptopoulos VD; Avigan DE; Yam CS; Kruskal JB; Pedrosa I
AJR Am J Roentgenol; 2011 May; 196(5):1094-101. PubMed ID: 21512075
[TBL] [Abstract][Full Text] [Related]
10. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
[TBL] [Abstract][Full Text] [Related]
11. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.
Moore A; Dickerson E; Dillman JR; Vummidi D; Kershaw DB; Khalatbari S; Davenport MS
Curr Probl Diagn Radiol; 2014; 43(5):237-41. PubMed ID: 24909428
[TBL] [Abstract][Full Text] [Related]
12. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels.
Herts BR; Schneider E; Poggio ED; Obuchowski NA; Baker ME
Radiology; 2008 Jul; 248(1):106-13. PubMed ID: 18458249
[TBL] [Abstract][Full Text] [Related]
13. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
Kim SM; Cha RH; Lee JP; Kim DK; Oh KH; Joo KW; Lim CS; Kim S; Kim YS
Am J Kidney Dis; 2010 Jun; 55(6):1018-25. PubMed ID: 20097462
[TBL] [Abstract][Full Text] [Related]
14. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
15. Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
Kama A; Yılmaz S; Yaka E; Dervişoğlu E; Doğan NÖ; Erimşah E; Pekdemir M
Acad Emerg Med; 2014 Jun; 21(6):615-22. PubMed ID: 25039544
[TBL] [Abstract][Full Text] [Related]
16. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
[TBL] [Abstract][Full Text] [Related]
18. Low-contrast dose protection protocol for diagnostic computed tomography in patients at high-risk for contrast-induced nephropathy.
Kidoh M; Nakaura T; Awai K; Matsunaga Y; Tanoue K; Harada K; Uemura S; Yamashita Y
J Comput Assist Tomogr; 2013; 37(2):289-96. PubMed ID: 23493222
[TBL] [Abstract][Full Text] [Related]
19. Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography.
Moos SI; Stoker J; Nagan G; de Weijert RS; van Vemde DN; Bipat S
Eur Radiol; 2014 Jun; 24(6):1266-75. PubMed ID: 24663822
[TBL] [Abstract][Full Text] [Related]
20. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
